Zaderej Karen L.
Insider CIK 1530968 · EYPT Director · AXGN Chief Executive Officer, Director · VIVE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EYPT EyePoint, Inc. | P Buy | 2026-08-18 | 2026-08-18 | 10,600 | $4.93 | $52.3K | 49,100 | SEC↗ |
| EYPT EyePoint, Inc. | P Buy | 2026-08-18 | 2026-08-18 | 10,600 | $4.93 | $52.3K | 49,100 | SEC↗ |
| EYPT EyePoint, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2025-07-11 | 2025-07-11 | 2,000 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2025-07-11 | 2025-07-11 | 2,000 | — | $0 | 38,500 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | P Buy | 2025-05-19 | 2025-05-19 | 5,000 | $5.99 | $29.9K | 36,500 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | P Buy | 2025-05-16 | 2025-05-19 | 5,000 | $5.81 | $29.0K | 31,500 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | P Buy | 2025-05-15 | 2025-05-15 | 5,000 | $5.47 | $27.4K | 26,500 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | P Buy | 2025-05-14 | 2025-05-15 | 5,000 | $5.42 | $27.1K | 21,500 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2025-01-03 | 2025-01-07 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | P Buy | 2024-08-19 | 2024-08-21 | 12,500 | $7.98 | $99.8K | 16,500 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2024-07-11 | 2024-07-12 | 2,000 | — | $0 | 2,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2024-07-11 | 2024-07-12 | 2,000 | — | $0 | 4,000 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2024-03-21 | 2024-03-25 | 3,166 | $7.68 | $24.3K | 1,143,788 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2024-03-21 | 2024-03-25 | 3,086 | $7.68 | $23.7K | 1,133,979 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2024-03-21 | 2024-03-25 | 33,028 | $7.68 | $253.7K | 1,124,565 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2024-03-16 | 2024-03-25 | 84,847 | — | $0 | 84,847 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2024-03-16 | 2024-03-25 | 12,500 | — | $0 | 12,500 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2024-03-16 | 2024-03-25 | 12,975 | — | $0 | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2024-03-16 | 2024-03-25 | 84,847 | — | $0 | 1,157,593 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2024-03-16 | 2024-03-25 | 12,500 | — | $0 | 1,137,065 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2024-03-16 | 2024-03-25 | 12,975 | — | $0 | 1,146,954 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2024-01-05 | 2024-01-09 | 25,014 | — | $0 | 25,014 | SEC↗ |
| AXGN Axogen, Inc. | A Award | 2023-07-18 | 2023-10-13 | 22,076 | — | $0 | 1,072,746 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2023-07-11 | 2023-07-12 | 2,000 | — | $0 | 4,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2023-07-11 | 2023-07-12 | 2,000 | — | $0 | 2,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2023-06-20 | 2023-06-22 | 26,100 | — | $0 | 26,100 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2023-06-20 | 2023-06-22 | 13,000 | — | $0 | 13,000 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2023-03-16 | 2023-03-20 | 12,975 | — | $0 | 12,975 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2023-03-16 | 2023-03-20 | 179,000 | — | $0 | 179,000 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2023-03-16 | 2023-03-20 | 112,000 | — | $0 | 112,000 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2023-03-16 | 2023-03-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2023-03-16 | 2023-03-20 | 25,000 | — | $0 | 1,037,695 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2023-03-16 | 2023-03-20 | 12,975 | — | $0 | 1,050,670 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2022-12-27 | 2022-12-29 | 4,400 | — | $0 | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2022-12-27 | 2022-12-29 | 4,400 | — | $0 | 1,012,695 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2022-12-15 | 2022-12-16 | 26,746 | — | $0 | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2022-12-15 | 2022-12-16 | 26,746 | $5.09 | $136.1K | 1,008,295 | SEC↗ |
| AXGN Axogen, Inc. | D To issuer | 2022-07-19 | 2022-07-20 | 9,081 | $8.40 | $76.3K | 981,549 | SEC↗ |
| AXGN Axogen, Inc. | A Award | 2022-07-18 | 2022-07-20 | 22,076 | — | $0 | 988,409 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2022-07-11 | 2022-07-13 | 6,000 | — | $0 | 6,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2022-07-11 | 2022-07-13 | 22,000 | — | $0 | 22,000 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2022-03-16 | 2022-03-18 | 25,950 | — | $0 | 25,950 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2022-03-16 | 2022-03-18 | 317,185 | — | $0 | 317,185 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2022-03-16 | 2022-03-18 | 169,694 | — | $0 | 169,694 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2022-03-16 | 2022-03-18 | 25,950 | — | $0 | 966,333 | SEC↗ |
| AXGN Axogen, Inc. | A Award | 2022-02-15 | 2022-02-17 | 13,978 | — | $0 | 940,383 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2021-12-27 | 2021-12-29 | 4,400 | — | $0 | 4,400 | SEC↗ |
| AXGN Axogen, Inc. | F Tax w/h | 2021-12-27 | 2021-12-29 | 1,752 | $9.74 | $17.1K | 925,677 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2021-12-27 | 2021-12-29 | 4,400 | — | $0 | 927,429 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2021-12-20 | 2021-12-22 | 3,125 | — | $0 | 0 | SEC↗ |
| AXGN Axogen, Inc. | F Tax w/h | 2021-12-20 | 2021-12-22 | 1,243 | $9.24 | $11.5K | 923,029 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2021-12-20 | 2021-12-22 | 3,125 | — | $0 | 924,272 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2021-11-24 | 2021-11-29 | 52,375 | $8.95 | $468.8K | 157,125 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2021-11-24 | 2021-11-29 | 52,375 | $8.95 | $468.8K | 921,147 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2021-08-13 | 2021-08-16 | 46,500 | $3.67 | $170.7K | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2021-08-13 | 2021-08-16 | 46,500 | $3.67 | $170.7K | 868,772 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2021-08-12 | 2021-08-16 | 8,254 | $5.09 | $42.0K | 26,746 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2021-08-12 | 2021-08-16 | 8,254 | $5.09 | $42.0K | 822,272 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2021-08-10 | 2021-08-10 | 75,000 | $5.09 | $381.8K | 35,000 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2021-08-10 | 2021-08-10 | 75,000 | $5.09 | $381.8K | 855,018 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2021-08-06 | 2021-08-10 | 2,083 | $19.16 | $39.9K | 814,018 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2021-08-06 | 2021-08-10 | 22,902 | $18.41 | $421.6K | 816,101 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2021-08-06 | 2021-08-10 | 1,259 | $19.18 | $24.1K | 839,003 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2021-08-06 | 2021-08-10 | 14,756 | $18.40 | $271.5K | 840,262 | SEC↗ |
| AXGN Axogen, Inc. | F Tax w/h | 2021-07-20 | 2021-07-21 | 8,812 | $19.20 | $169.2K | 780,018 | SEC↗ |
| AXGN Axogen, Inc. | A Award | 2021-07-19 | 2021-07-21 | 22,077 | — | $0 | 788,830 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2021-04-16 | 2021-04-20 | 100,000 | $5.09 | $509.0K | 110,000 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2021-04-16 | 2021-04-20 | 100,000 | $5.09 | $509.0K | 765,912 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2021-03-25 | 2021-03-29 | 19,000 | $3.67 | $69.7K | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2021-03-25 | 2021-03-29 | 15,500 | $3.67 | $56.9K | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2021-03-25 | 2021-03-29 | 34,500 | $3.67 | $126.6K | 665,912 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2021-03-16 | 2021-03-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2021-03-16 | 2021-03-18 | 76,600 | — | $0 | 76,600 | SEC↗ |
| AXGN Axogen, Inc. | F Tax w/h | 2021-02-17 | 2021-02-18 | 3,504 | $18.71 | $65.6K | 631,412 | SEC↗ |
| AXGN Axogen, Inc. | F Tax w/h | 2021-02-17 | 2021-02-18 | 4,182 | $18.71 | $78.2K | 620,938 | SEC↗ |
| AXGN Axogen, Inc. | A Award | 2021-02-16 | 2021-02-18 | 16,021 | — | $0 | 625,120 | SEC↗ |
| AXGN Axogen, Inc. | A Award | 2021-02-16 | 2021-02-18 | 13,978 | — | $0 | 634,916 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2021-01-08 | 2021-01-12 | 65,000 | $20.00 | $1.30M | 609,099 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2020-12-29 | 2020-12-30 | 3,500 | $17.81 | $62.3K | 674,099 | SEC↗ |
| AXGN Axogen, Inc. | A Award | 2020-12-27 | 2020-12-30 | 8,800 | — | $0 | 677,599 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2020-12-23 | 2020-12-28 | 19,375 | — | $0 | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2020-12-23 | 2020-12-28 | 19,375 | $4.81 | $93.2K | 666,094 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2020-12-21 | 2020-12-22 | 1,275 | $16.42 | $20.9K | 646,719 | SEC↗ |
| AXGN Axogen, Inc. | A Award | 2020-12-18 | 2020-12-22 | 3,125 | — | $0 | 647,994 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2020-11-09 | 2020-11-10 | 14,000 | $14.53 | $203.4K | 644,869 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2020-04-16 | 2020-04-20 | 11,625 | — | $0 | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2020-04-16 | 2020-04-20 | 11,625 | $4.81 | $55.9K | 658,869 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2020-03-16 | 2020-03-18 | 80,200 | — | $0 | 80,200 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2020-03-16 | 2020-03-18 | 51,900 | — | $0 | 51,900 | SEC↗ |
| AXGN Axogen, Inc. | A Award | 2020-02-18 | 2020-02-20 | 13,978 | — | $0 | 636,658 | SEC↗ |
| AXGN Axogen, Inc. | F Tax w/h | 2020-02-18 | 2020-02-20 | 5,429 | $14.68 | $79.7K | 631,229 | SEC↗ |
| AXGN Axogen, Inc. | A Award | 2020-02-18 | 2020-02-20 | 16,015 | — | $0 | 647,244 | SEC↗ |
| AXGN Axogen, Inc. | A Award | 2020-01-01 | 2020-01-17 | 40,000 | — | $0 | 632,792 | SEC↗ |
| AXGN Axogen, Inc. | D To issuer | 2020-01-01 | 2020-01-17 | 10,112 | $17.34 | $175.3K | 622,680 | SEC↗ |
| AXGN Axogen, Inc. | A Award | 2019-12-18 | 2019-12-20 | 6,250 | — | $0 | 599,530 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award deriv | 2019-11-26 | 2019-11-27 | 330,000 | — | $0 | 330,000 | SEC↗ |
| AXGN Axogen, Inc. | P Buy | 2019-08-09 | 2019-08-12 | 75,000 | $13.50 | $1.01M | 593,280 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award | 2019-07-01 | 2019-07-02 | 37,829 | — | $0 | 62,347 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2019-05-29 | 2019-05-31 | 18,056 | — | $0 | 0 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award deriv | 2019-05-29 | 2019-05-31 | 35,000 | — | $0 | 35,000 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2019-05-29 | 2019-05-31 | 18,056 | $0.27 | $4.9K | 510,280 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award | 2019-04-01 | 2019-04-03 | 14,248 | — | $0 | 24,518 | SEC↗ |
| AXGN AxoGen, Inc. | A Award | 2019-02-15 | 2019-02-19 | 16,015 | $17.57 | $281.4K | 492,224 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award | 2018-12-31 | 2019-01-02 | 9,524 | — | $0 | 10,270 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2018-12-27 | 2018-12-31 | 59,700 | — | $0 | 59,700 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2018-12-27 | 2018-12-31 | 17,600 | — | $0 | 17,600 | SEC↗ |
| AXGN AxoGen, Inc. | M Exercise deriv | 2018-12-19 | 2018-12-21 | 30,000 | — | $0 | 0 | SEC↗ |
| AXGN AxoGen, Inc. | M Exercise deriv | 2018-11-19 | 2018-11-21 | 70,000 | — | $0 | 0 | SEC↗ |
| AXGN AxoGen, Inc. | F Tax w/h | 2018-11-19 | 2018-11-21 | 6,761 | $28.37 | $191.8K | 446,209 | SEC↗ |
| AXGN AxoGen, Inc. | M Exercise | 2018-11-19 | 2018-11-21 | 70,000 | $2.74 | $191.8K | 452,970 | SEC↗ |
| AXGN AxoGen, Inc. | M Exercise | 2018-11-19 | 2018-12-21 | 30,000 | $2.74 | $82.2K | 476,209 | SEC↗ |
| AXGN AxoGen, Inc. | S Sale | 2018-11-14 | 2018-11-15 | 12,000 | $32.93 | $395.2K | 382,970 | SEC↗ |
| AXGN AxoGen, Inc. | S Sale | 2018-11-13 | 2018-11-15 | 13,000 | $33.42 | $434.5K | 394,970 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award | 2018-10-01 | 2018-10-04 | 746 | — | $0 | 746 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award deriv | 2018-09-13 | 2018-09-14 | 70,000 | — | $0 | 70,000 | SEC↗ |
| AXGN AxoGen, Inc. | F Tax w/h | 2018-08-07 | 2018-08-09 | 10,060 | $39.30 | $395.4K | 407,970 | SEC↗ |
| AXGN AxoGen, Inc. | M Exercise deriv | 2018-08-02 | 2018-08-06 | 175,000 | — | $0 | 100,000 | SEC↗ |
| AXGN AxoGen, Inc. | M Exercise | 2018-08-02 | 2018-08-06 | 175,000 | $2.74 | $479.5K | 418,030 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2017-12-18 | 2017-12-20 | 75,000 | — | $0 | 75,000 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2017-12-18 | 2017-12-20 | 12,500 | — | $0 | 12,500 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2016-12-29 | 2017-01-03 | 209,500 | — | $0 | 209,500 | SEC↗ |
| AXGN AxoGen, Inc. | A Award | 2016-12-29 | 2017-01-03 | 40,000 | — | $0 | 282,147 | SEC↗ |
| AXGN AxoGen, Inc. | P Buy | 2016-10-07 | 2016-10-14 | 10,000 | $7.50 | $75.0K | 242,147 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2015-12-28 | 2016-05-31 | 210,000 | — | $0 | 210,000 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2015-12-28 | 2015-12-30 | 210,000 | — | $0 | 210,000 | SEC↗ |
| AXGN AxoGen, Inc. | P Buy | 2015-05-27 | 2015-05-29 | 2,625 | $3.17 | $8.3K | 231,447 | SEC↗ |
| AXGN AxoGen, Inc. | P Buy | 2015-05-27 | 2015-05-29 | 200 | $3.11 | $622 | 232,147 | SEC↗ |
| AXGN AxoGen, Inc. | P Buy | 2015-05-27 | 2015-05-29 | 500 | $3.10 | $1.6K | 231,947 | SEC↗ |
| AXGN AxoGen, Inc. | A Award | 2015-02-10 | 2015-02-12 | 9,600 | $2.75 | $26.4K | 228,822 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2014-12-29 | 2014-12-31 | 62,000 | — | $0 | 386,056 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2014-12-29 | 2014-12-31 | 19,000 | — | $0 | 405,056 | SEC↗ |
| AXGN AxoGen, Inc. | P Buy | 2014-06-03 | 2014-06-04 | 5,000 | $2.43 | $12.2K | 334,056 | SEC↗ |
| AXGN AxoGen, Inc. | P Buy | 2014-05-12 | 2014-05-13 | 5,000 | $2.70 | $13.5K | 329,056 | SEC↗ |
| AXGN AxoGen, Inc. | M Exercise deriv | 2014-03-14 | 2014-03-17 | 72,222 | — | $0 | 324,056 | SEC↗ |
| AXGN AxoGen, Inc. | M Exercise deriv | 2014-03-14 | 2014-03-17 | 126 | — | $0 | 251,834 | SEC↗ |
| AXGN AxoGen, Inc. | M Exercise | 2014-03-14 | 2014-03-17 | 126 | $0.27 | $34 | 137,000 | SEC↗ |
| AXGN AxoGen, Inc. | M Exercise | 2014-03-14 | 2014-03-17 | 72,222 | $0.27 | $19.5K | 209,222 | SEC↗ |
| AXGN AxoGen, Inc. | P Buy | 2014-03-13 | 2014-03-17 | 572 | $3.47 | $2.0K | 136,874 | SEC↗ |
| AXGN AxoGen, Inc. | P Buy | 2014-03-13 | 2014-03-17 | 928 | $3.50 | $3.2K | 136,302 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2014-01-02 | 2014-01-06 | 31,000 | — | $0 | 396,404 | SEC↗ |
| AXGN AxoGen, Inc. | A Award | 2014-01-02 | 2014-01-06 | 6,250 | — | $0 | 135,374 | SEC↗ |
| AXGN AxoGen, Inc. | P Buy | 2013-08-14 | 2013-08-15 | 8,334 | $3.00 | $25.0K | 129,124 | SEC↗ |
| AXGN AxoGen, Inc. | P Buy | 2012-12-10 | 2012-12-13 | 900 | $2.50 | $2.3K | 120,790 | SEC↗ |
| AXGN AxoGen, Inc. | P Buy | 2012-11-20 | 2012-11-23 | 100 | $2.69 | $269 | 119,890 | SEC↗ |